Stocks and Investing
Stocks and Investing
Wed, January 18, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, January 17, 2023
[ 12:00 AM ] - United States, WOPRAI
Steve Valiquette Maintained (DOC) at Buy with Decreased Target to $18 on, Jan 17th, 2023
Steve Valiquette of Barclays, Maintained "Healthpeak Properties, Inc." (DOC) at Buy with Decreased Target from $20 to $18 on, Jan 17th, 2023.
Steve has made no other calls on DOC in the last 4 months.
There are 3 other peers that have a rating on DOC. Out of the 3 peers that are also analyzing DOC, 2 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Richard Hill of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Tuesday, November 1st, 2022
- Michael Mueller of "JP Morgan" Initiated at Hold and Held Target at $17 on, Friday, October 28th, 2022
This is the rating of the analyst that currently disagrees with Steve
- Todd Thomas of "Keybanc" Upgraded from Hold to Buy and Held Target at $17 on, Wednesday, December 14th, 2022
Contributing Sources